Procter & Gamble Hygiene and Health Care Ltd. announced its Q3 results, reporting sales of ₹1262 crore, a 1% increase year-over-year. Profit After Tax (PAT) rose by 12% to ₹301 crore, driven by operational efficiencies and a favorable product mix. The company declared an interim dividend of ₹195 per Equity Share for FY 2025-26.
Financial Performance Highlights
Procter & Gamble Hygiene and Health Care Ltd. reported sales of ₹1262 crore for the quarter ended December 31, 2025 (Q3), representing a 1% growth compared to the same period last year. The Profit After Tax (PAT) for the quarter stood at ₹301 crore, a 12% increase year-over-year. This increase was attributed to improved operational efficiencies and a beneficial product price-mix.
Dividend Announcement
The company has declared an interim dividend of ₹195 per Equity Share, including a one-time special dividend of ₹25 per Equity Share, for the financial year 2025-26.
Management Commentary
Kumar Venkatasubramanian, Managing Director, stated that the company remains committed to its integrated growth strategy. This includes a focused product portfolio, superiority in product performance, and constructive disruption, to drive balanced growth and value creation. The company continues to invest to delight consumers, which is reflected in its stable performance.
Source: BSE
